Prosight Management, LP - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,314,000
+83.5%
444,068
+128.1%
0.73%
+39.6%
Q2 2018$716,000
-12.3%
194,663
-16.5%
0.52%
+2.5%
Q1 2018$816,000
-11.8%
233,003
-21.4%
0.51%
-24.7%
Q4 2017$925,000296,4880.68%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 1,800,000$1,404,0002.63%
Stonepine Capital Management, LLC 491,096$383,0000.26%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 918,342$716,0000.05%
KNOTT DAVID M 109,135$85,0000.04%
EdgePoint Investment Group Inc. 2,831,555$2,209,0000.02%
Yakira Capital Management, Inc. 36,428$28,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$36,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 85,409$66,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 37,717$29,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders